Satsuma Pharmaceuticals Inc. sell klostergang
Start price
11.09.20
/
50%
€4.30
Target price
04.11.21
€2.00
Performance (%)
16.74%
End price
17.06.21
€5.02
Summary
This prediction ended on 17.06.21 with a price of €5.02. The SELL prediction by klostergang finished with a performance of 16.74%. klostergang has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Satsuma Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | 1.937% | 1.473% | 18.596% | 15.757% |
iShares Nasdaq 100 | -1.186% | -0.040% | 27.123% | 35.363% |
iShares Nikkei 225® | 1.938% | 4.205% | 17.502% | 10.532% |
iShares S&P 500 | -0.023% | 0.109% | 24.843% | 36.692% |
According to klostergang what are the pros and cons of Satsuma Pharmaceuticals Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
Risky balance sheet
ROE lower than 10% per year
No uniques
Growths much slower than the competition
Higher risks for its business
Nicheplayer
Little known brand
Comments by klostergang for this prediction
In the thread Satsuma Pharmaceuticals Inc. diskutieren
Sell mit Kursziel 2,0